Genmab — Januar 2015
-
400 snart
-
393
-
BTW JP Morgan har ikke dækning af genmabaktien pt. så vidt jeg ved. Kan være de vil til at have dette? siden genmab nu skal præsentere der
-
Derfor han skal sige Arzerra og Zydelic
mere mundret -
Bare du ikke siger Zalutumumab Helge så begynder vi at få røde knopper herinde

-
Jeg kiggede på det i går, som jeg læser det blev arzerra givet i 3rd line ved at søge betaling gennem fonden. Det er pillet ud fordi der nu er en bedre behandling i 3rd line, nemlig ibrutinib. 1stline går gennem det "normale" system
-
det er da først torsdag solsen? hvis det er jp morgan
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
